查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1879261

药物依从性市场－全球产业规模、份额、趋势、机会和预测，按类型、药物、地区和竞争格局划分，2020-2030年预测

Medication Adherence Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Medication, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 187 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024年全球药物依从性市场规模为26.6亿美元，预计2030年将以5.30%的复合年增长率成长至36.3亿美元。药物依从性解决方案涵盖旨在确保患者持续遵循处方药物方案（包括剂量、用药时间和频率）的技术和服务。此市场成长的主要驱动因素包括：慢性疾病（如糖尿病和心血管疾病）在全球范围内的日益流行；需要长期治疗的老年人口不断增长；以及医疗保健技术的不断进步，包括智慧型手机在健康管理领域的广泛应用。此外，以患者为中心的护理模式的日益普及以及医疗保健生态系统内合作的不断加强也进一步推动了该市场的发展。

市场概览
预测期 2026-2030
2024年市场规模 26.6亿美元
2030年市场规模 36.3亿美元
2025-2030年复合年增长率 5.3%
成长最快的细分市场 肿瘤学
最大的市场 北美洲

主要市场驱动因素

主要市场挑战

主要市场趋势

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：客户之声

第五章：全球药物依从性市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依类型（硬体中心型、软体中心型）
    • 依药物分类（心血管、中枢神经、糖尿病、肿瘤、胃肠道、肌肉骨骼、其他）
    • 按地区
    • 按公司（2024 年）
  • 市场地图

第六章：北美药物依从性市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第七章：欧洲药物依从性市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国家分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区药物依从性市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲药物依从性市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东和非洲：国家分析
    • 沙乌地阿拉伯
    • 阿联酋
    • 南非

第十章：南美洲药物依从性市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国家分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章：市场动态

  • 司机
  • 挑战

第十二章：市场趋势与发展

  • 併购（如有）
  • 产品发布（如有）
  • 最新进展

第十三章：全球药物依从性市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商议价能力
  • 顾客的力量
  • 替代产品的威胁

第十五章：竞争格局

  • AdhereTech Inc.
  • Cardinal Health Inc.
  • Everwell Technology Ltd
  • InhandPlus Inc.
  • Johnson & Johnson
  • Koninklijke Philips NV
  • McKesson Corporation
  • MedAdvisor International Pty Ltd
  • Medminder Systems, Inc.
  • Omnicell, Inc.

第十六章：策略建议

第17章调查会社について・免责事项

简介目录
Product Code: 19888

The Global Medication Adherence Market, valued at USD 2.66 Billion in 2024, is projected to experience a CAGR of 5.30% to reach USD 3.63 Billion by 2030. Medication adherence solutions encompass technologies and services designed to ensure patients consistently follow prescribed medication regimens concerning dosage, timing, and frequency. This market's growth is primarily driven by the escalating global prevalence of chronic diseases, such as diabetes and cardiovascular conditions, the expanding geriatric population requiring long-term treatment, and continuous advancements in healthcare technology, including widespread smartphone adoption for health management. Further impetus comes from a growing emphasis on patient-centric care models and increasing collaborations across the healthcare ecosystem.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 2.66 Billion
Market Size 2030USD 3.63 Billion
CAGR 2025-20305.3%
Fastest Growing SegmentOncology
Largest MarketNorth America

Key Market Drivers

The escalating prevalence of chronic diseases represents a primary driver for the global medication adherence market. Conditions such as diabetes, cardiovascular disease, and respiratory ailments necessitate long-term medication regimens, often complex, for effective management and prevention of severe complications. The sheer scale of this challenge underscores the critical need for solutions that support consistent patient adherence. According to the International Diabetes Federation, in 2024, 589 million adults aged 20 to 79 years are living with diabetes, a condition demanding rigorous medication adherence to mitigate serious health consequences and healthcare burdens.

Key Market Challenges

The high cost of pharmaceuticals and patient cost-sharing presents a significant challenge to the growth of the Global Medication Adherence Market. When medication expenses become prohibitive, patients frequently resort to strategies such as reducing prescribed dosages, delaying refills, or entirely discontinuing essential treatments. This financial impediment directly undermines the utility and adoption of medication adherence solutions, as patients prioritize immediate cost reduction over long-term health management facilitated by adherence technologies.

Key Market Trends

The integration of Artificial Intelligence in adherence monitoring is fundamentally transforming how patients engage with their prescribed treatments. AI-powered platforms leverage advanced algorithms to analyze patient behavior, identify non-adherence patterns, and deliver highly personalized interventions, moving beyond generic reminders. These intelligent systems facilitate predictive analytics to pinpoint individuals at high risk of non-adherence, enabling proactive support. According to American Medical Association survey data, 66% of physicians reported using AI in their practices in 2024, a significant increase from 38% in 2023, demonstrating growing adoption of AI in clinical settings. This technological shift enhances the effectiveness of medication management by tailoring support to individual patient needs.

Key Market Players

  • AdhereTech Inc.
  • Cardinal Health Inc.
  • Everwell Technology Ltd
  • InhandPlus Inc.
  • Johnson & Johnson
  • Koninklijke Philips N.V.
  • McKesson Corporation
  • MedAdvisor International Pty Ltd
  • Medminder Systems, Inc.
  • Omnicell, Inc.

Report Scope:

In this report, the Global Medication Adherence Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Medication Adherence Market, By Type:

  • Hardware Centric
  • Software Centric

Medication Adherence Market, By Medication:

  • Cardiovascular
  • Central Nervous System
  • Diabetes
  • Oncology
  • Gastrointestinal
  • Musculoskeletal
  • Others

Medication Adherence Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Medication Adherence Market.

Available Customizations:

Global Medication Adherence Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Medication Adherence Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Hardware Centric, Software Centric)
    • 5.2.2. By Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Medication Adherence Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Medication
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Medication Adherence Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Medication
    • 6.3.2. Canada Medication Adherence Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Medication
    • 6.3.3. Mexico Medication Adherence Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Medication

7. Europe Medication Adherence Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Medication
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Medication Adherence Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Medication
    • 7.3.2. France Medication Adherence Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Medication
    • 7.3.3. United Kingdom Medication Adherence Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Medication
    • 7.3.4. Italy Medication Adherence Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Medication
    • 7.3.5. Spain Medication Adherence Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Medication

8. Asia Pacific Medication Adherence Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Medication
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Medication Adherence Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Medication
    • 8.3.2. India Medication Adherence Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Medication
    • 8.3.3. Japan Medication Adherence Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Medication
    • 8.3.4. South Korea Medication Adherence Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Medication
    • 8.3.5. Australia Medication Adherence Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Medication

9. Middle East & Africa Medication Adherence Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Medication
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Medication Adherence Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Medication
    • 9.3.2. UAE Medication Adherence Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Medication
    • 9.3.3. South Africa Medication Adherence Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Medication

10. South America Medication Adherence Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Medication
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Medication Adherence Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Medication
    • 10.3.2. Colombia Medication Adherence Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Medication
    • 10.3.3. Argentina Medication Adherence Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Medication

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Medication Adherence Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. AdhereTech Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Cardinal Health Inc.
  • 15.3. Everwell Technology Ltd
  • 15.4. InhandPlus Inc.
  • 15.5. Johnson & Johnson
  • 15.6. Koninklijke Philips N.V.
  • 15.7. McKesson Corporation
  • 15.8. MedAdvisor International Pty Ltd
  • 15.9. Medminder Systems, Inc.
  • 15.10. Omnicell, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer